Riskpilot← Back to searchSign inGet full accessNapraWell AB
ABActiveOrg 5569171266Trädgårdsgatan 26 1trPhysiotherapy activities · NACE 8695Est. 20123 employees
Revenue 2025
SEK 5M
+75% vs 2024
EBITDA margin
11.1%
-11% vs 2024
Equity ratio
51.0%
Financial strength
Net profit 2025
SEK 418K
+17% vs 2024
| Revenue | SEK 5M | +75% |
| EBITDA | SEK 554K | -11% |
| Net profit | SEK 418K | +17% |
| Total assets | SEK 1,3M | +5% |
| Equity | SEK 650K | -11% |
| Employees | 3 | — |
Legal name
NapraWell AB
Org number
5569171266
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
28 december 2012
Share capital
SEK 51 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva klinik med naprapatbehandlingar samt därmed förenligt verksamhet.
Address
Trädgårdsgatan 26 1tr
Email
kontakta@naprawell.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 728 | 599 | 1 049 | 2 855 | 4 990 |
| Staff expenses | — | — | −51 | −1 146 | −2 875 |
| EBITDA | −51 | −5 | 548 | 624 | 554 |
| Depreciation & amort. | −0 | −0 | — | −10 | −19 |
| EBIT | −51 | −5 | 548 | 614 | 535 |
| Net financials | — | — | 2 | 1 | −3 |
| Profit before tax | −51 | −5 | 412 | 455 | 533 |
| Tax | −0 | −0 | −86 | −99 | 115 |
| Net profit | −51 | −5 | 327 | 356 | 418 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 249 | 285 | 633 | 1 216 | 1 276 |
| Equity | 143 | 139 | 377 | 733 | 650 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 106 | 146 | 118 | 185 | 328 |
| Total debt | 106 | 146 | 118 | 185 | 328 |
EBITDA margin
11.1%
This company
15.8%
Market median
-30% vs market
20212025
Equity ratio
51.0%
This company
38.2%
Market median
+34% vs market
20212025
Return on equity
64.2%
This company
18.4%
Market median
+249% vs market
20212025
Net profit margin
8.4%
This company
8.1%
Market median
+4% vs market
20212025
Asset turnover
3.91×
This company
1.12×
Market median
+249% vs market
20212025
Debt / equity
0.96×
This company
0.62×
Market median
+55% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RT Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2024 | |
| Former (3) | ||
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2025 – 2025 | |
| Board of Directors | 2024 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NapraWell AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rafael Touma | Chief Executive Officer | 0 companies |
| Marjam Caroline Arkan | Board of Directors | 0 companies |
| Alen Jasmin Manovic | Board of Directors | 0 companies |
| Erik Olaf Nygaard | Board of Directors | 0 companies |
| Agnes Naomi Okhiria | Deputy Board Member | 0 companies |
| David Cesar Rodriguez | Chairman | 0 companies |
| Mia Bomnes Valåmo | Deputy Board Member | 0 companies |